D-1373-2022 Class II Ongoing
FDA drug recall D-1373-2022 was initiated by Family Dollar Stores, Llc. on Jun 23, 2022 and is designated Class II. Reason for recall: CGMP Deviations: product held outside appropriate storage temperature conditions. The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 31, 2022
- Initiation Date
- Jun 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
MOTRIN IB CAPLETS 24CT SKU999394; GOOD SENSE IBUPROFEN 200MG TABLETS 24CT SKU 900556;GOOD SENSE IBUPROFEN 200MG CAPLET 50 CT SKU 902333 MOTRIN CHILDREN'S BUBBLEGUM 4 FL OZ SKU 903048 GOOD SENSE IBUPROFEN REGULAR SOFTGELS 160CT SKU 999373 GOOD SENSE IBUPROFEN 200 MG CAPLET 100 CT SKU 902359 MOTRIN IB CAPLET 50 CT SKU 900604 GOOD SENSE IBUPROFEN IB CAPLET 100 CT SKU 913989 GOOD SENSE IBUPROFEN 200 MG SOFTGEL 20CT SKU 916994 ADVIL LIQUID GEL 40 CT SKU 916071 GOOD SENSE IBUPROFEN PM 200 MG 20 CT SKU 917004 ADVIL PM CAPLET 20CT SKU 913010 GOOD SENSE IBUPROFEN TABLET 100 CT SKU 913991 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022. Specifically:
Reason for Recall
CGMP Deviations: product held outside appropriate storage temperature conditions.
Distribution Pattern
Nationwide within the United States
Code Information
SKUs: 999394; 900556; 902333; 903048; 999373; 902359; 900604 913989; 916994; 916071; 917004; 913010; 913991
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1373-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026